How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/peripheral-arterial-thromboembolism-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Peripheral Arterial Thromboembolism Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peripheral Arterial Thromboembolism Prevention (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Peripheral Arterial Thromboembolism Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Plavix	clopidogrel	Generic (originally Sanofi/BMS)	Thienopyridine antiplatelet agent	Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter	1997-11-17
Heparin Sodium In Plastic Container	HEPARIN	Merck & Co.	Anti-coagulant	Antithrombin-III	1939-01-01
Heparin Sodium In Plastic Container	Heparin Sodium	Fresenius Kabi	Anticoagulant	Antithrombin III, Coagulation Factors Xa and IIa	1939-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Fresenius Kabi · 1 drug in Peripheral Arterial Thromboembolism Prevention
Generic (originally Sanofi/BMS) · 1 drug in Peripheral Arterial Thromboembolism Prevention
Merck & Co. · 1 drug in Peripheral Arterial Thromboembolism Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Peripheral Arterial Thromboembolism Prevention:

Cite this brief

Drug Landscape (2026). Peripheral Arterial Thromboembolism Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/peripheral-arterial-thromboembolism-prevention. Accessed 2026-06-10.

Peripheral Arterial Thromboembolism Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing